drugset / Trial / NCT05572268

EFFICACY OF ANSA (Experimental Drug) & CRAN MAX (Control Drug) SACHET

NCT05572268 ↗

Phase 3 Unknown 100 enrolled Shifa Ul Mulk Memorial Hospital
RandomizedParallel-groupSingle-blindHealth-services research

Summary

I This clinical trial aims to VIVO AND IN VITRO COMPARATIVE STUDY ON EFFICACY OF ANSA (experimental drug) \& CRAN MAX (control drug) SACHET IN UNCOMPLICATED UTI in females. The main question\[s\] it aims to answer are: • Hypothesis I ANSA is an effective therapy for uncomplicated UTI treatment and inhibits or kills E.coli and other organisms in vitro and in vivo Null Hypothesis ANSA is not an effective therapy for uncomplicated UTI treatment and couldn't inhibit or kill E.coli and other organisms in vitro and in vivo Hypothesis II Cran Max is an effective therapy for uncomplicated UTIs and inhibits or kills E.coli and other organisms in vitro and in vivo Null Hypothesis Cran Max is not an effective therapy for uncomplicated UTI treatment and couldn't inhibit or kill E.coli and other organisms in vitro and in vivo

Timeline

Start
2021-08-12
Primary completion
2024-08-12
Completion
2024-08-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ansa Unknown — —
Subject Cran Max Unknown — —

Indications

No indication recorded.